Target intelligence / Profile preview

REXO1 like 6, pseudogene (REXO1L6P)

Target
REXO1L6P
Molecular classification
Other (Pseudogene)
01

Overview

REXO1 like 6, pseudogene (REXO1L6P) is a non-protein coding region of the human genome, closely resembling the RNA exonuclease 1 homolog but lacking the capacity to encode a functional protein due to accumulated mutations. As with most pseudogenes, REXO1L6P has no confirmed biological activity, molecular function, or disease association. It is not recognized as a therapeutic target in genomic databases or the scientific literature.

Other names
REXO1L6PREXO1-like 6 pseudogeneREXO1 Like 6 Pseudogene

Beyond the preview

Go deeper on REXO1 like 6, pseudogene (REXO1L6P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on REXO1 like 6, pseudogene (REXO1L6P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call